Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types
about
Chronic beryllium disease: an updated model interaction between innate and acquired immunityp53-dependent up-regulation of CDKN1A and down-regulation of CCNE2 in response to beryllium.Beryllium is an inhibitor of cellular GSK-3β that is 1,000-fold more potent than lithium.The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells.
P2860
Beryllium sulfate induces p21 CDKN1A expression and a senescence-like cell cycle arrest in susceptible cancer cell types
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@ast
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@en
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@nl
type
label
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@ast
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@en
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@nl
prefLabel
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@ast
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@en
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@nl
P2860
P1433
P1476
Beryllium sulfate induces p21 ...... susceptible cancer cell types
@en
P2093
Priyatham Gorjala
Ronald K Gary
P2860
P2888
P304
P356
10.1007/S10534-010-9352-Y
P577
2010-06-12T00:00:00Z
P5875
P6179
1007515032